Author:
Kang Benjamin,Xiao Hong,Ackley Todd,Shao Lina
Reference11 articles.
1. Mikhail FM, Biegel JA, Cooley LD, Dubuc AM, Hirsch B, Horner VL, Newman S, Shao L, Wolff DJ, Raca G (2019) Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC). Genet Med 21:1903–1916
2. Dutt A, Beroukhim R (2007) Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol 19:43–49
3. Wang Y, Armstrong SA (2007) Genome-wide SNP analysis in cancer: leukemia shows the way. Cancer Cell 11:308–309
4. Parsons DW, Li M, Zhang X et al (2011) The genetic landscape of the childhood cancer medulloblastoma. Science 331:435–439
5. Hester SD, Reid L, Nowak N, Jones WD, Parker JS, Knudtson K, Ward W, Tiesman J, Denslow ND (2009) Comparison of comparative genomic hybridization technologies across microarray platforms. J Biomol Tech 20:135–151